vs

Side-by-side financial comparison of Red Cat Holdings, Inc. (RCAT) and Wave Life Sciences Ltd. (WVE). Click either name above to swap in a different company.

Red Cat Holdings, Inc. is the larger business by last-quarter revenue ($9.6M vs $8.7M, roughly 1.1× Wave Life Sciences Ltd.). Red Cat Holdings, Inc. runs the higher net margin — -166.0% vs -580.2%, a 414.1% gap on every dollar of revenue. On growth, Red Cat Holdings, Inc. posted the faster year-over-year revenue change (988.2% vs -55.8%). Red Cat Holdings, Inc. produced more free cash flow last quarter ($-24.5M vs $-46.3M).

Mega Cat Studios is an American video game development and publishing company located in Pittsburgh, Pennsylvania. It was founded in 2015 by James Deighan, Nick Mann, and Zack Manko.

BIT Life Sciences is a for profit meetings, incentives, conferencing, exhibitions (MICE) company based in Dalian, China, that specializes in arranging multiple scientific congresses that have been described as "predatory". The company is part of a wave of organizations that have appeared in China in the past several years noted for arranging congresses with little academic merit and with the primary aim of generating revenue rather than scientific knowledge sharing. Papers submitted are usual...

RCAT vs WVE — Head-to-Head

Bigger by revenue
RCAT
RCAT
1.1× larger
RCAT
$9.6M
$8.7M
WVE
Growing faster (revenue YoY)
RCAT
RCAT
+1044.0% gap
RCAT
988.2%
-55.8%
WVE
Higher net margin
RCAT
RCAT
414.1% more per $
RCAT
-166.0%
-580.2%
WVE
More free cash flow
RCAT
RCAT
$21.8M more FCF
RCAT
$-24.5M
$-46.3M
WVE

Income Statement — Q3 FY2025 vs Q2 FY2025

Metric
RCAT
RCAT
WVE
WVE
Revenue
$9.6M
$8.7M
Net Profit
$-16.0M
$-50.5M
Gross Margin
6.6%
Operating Margin
-181.7%
-606.5%
Net Margin
-166.0%
-580.2%
Revenue YoY
988.2%
-55.8%
Net Profit YoY
-29.0%
-53.3%
EPS (diluted)
$-0.16
$-0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RCAT
RCAT
WVE
WVE
Q3 25
$9.6M
Q2 25
$8.7M
Q1 25
$1.6M
$9.2M
Q4 24
$0
Q2 24
$19.7M
Q1 24
$5.8M
$12.5M
Q4 23
$29.1M
Q3 23
$49.2M
Net Profit
RCAT
RCAT
WVE
WVE
Q3 25
$-16.0M
Q2 25
$-50.5M
Q1 25
$-23.1M
$-46.9M
Q4 24
$-13.3M
Q2 24
$-32.9M
Q1 24
$-5.5M
$-31.6M
Q4 23
$-16.3M
Q3 23
$7.3M
Gross Margin
RCAT
RCAT
WVE
WVE
Q3 25
6.6%
Q2 25
Q1 25
-52.2%
Q4 24
Q2 24
Q1 24
18.8%
Q4 23
Q3 23
Operating Margin
RCAT
RCAT
WVE
WVE
Q3 25
-181.7%
Q2 25
-606.5%
Q1 25
-765.7%
-542.8%
Q4 24
Q2 24
-177.7%
Q1 24
-76.0%
-274.8%
Q4 23
-64.3%
Q3 23
9.0%
Net Margin
RCAT
RCAT
WVE
WVE
Q3 25
-166.0%
Q2 25
-580.2%
Q1 25
-1418.9%
-510.9%
Q4 24
Q2 24
-167.2%
Q1 24
-93.9%
-251.7%
Q4 23
-55.9%
Q3 23
14.7%
EPS (diluted)
RCAT
RCAT
WVE
WVE
Q3 25
$-0.16
Q2 25
$-0.31
Q1 25
$-0.27
$-0.29
Q4 24
Q2 24
$-0.25
Q1 24
$-0.24
Q4 23
$-0.14
Q3 23
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RCAT
RCAT
WVE
WVE
Cash + ST InvestmentsLiquidity on hand
$208.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$253.3M
$139.3M
Total Assets
$286.0M
$252.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RCAT
RCAT
WVE
WVE
Q3 25
Q2 25
$208.5M
Q1 25
$243.1M
Q4 24
Q2 24
$154.0M
Q1 24
$180.9M
Q4 23
$200.4M
Q3 23
$139.9M
Stockholders' Equity
RCAT
RCAT
WVE
WVE
Q3 25
$253.3M
Q2 25
$139.3M
Q1 25
$28.9M
$171.8M
Q4 24
$27.0M
Q2 24
$-3.5M
Q1 24
$49.6M
$25.4M
Q4 23
$39.6M
Q3 23
$-40.5M
Total Assets
RCAT
RCAT
WVE
WVE
Q3 25
$286.0M
Q2 25
$252.4M
Q1 25
$59.7M
$288.3M
Q4 24
$51.1M
Q2 24
$208.8M
Q1 24
$55.3M
$235.3M
Q4 23
$274.9M
Q3 23
$199.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RCAT
RCAT
WVE
WVE
Operating Cash FlowLast quarter
$-23.9M
$-46.0M
Free Cash FlowOCF − Capex
$-24.5M
$-46.3M
FCF MarginFCF / Revenue
-254.2%
-532.5%
Capex IntensityCapex / Revenue
6.9%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-55.0M
$-170.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RCAT
RCAT
WVE
WVE
Q3 25
$-23.9M
Q2 25
$-46.0M
Q1 25
$-15.9M
$-63.0M
Q4 24
$-10.1M
Q2 24
$-27.5M
Q1 24
$-4.1M
$-33.4M
Q4 23
$-33.2M
Q3 23
$-34.5M
Free Cash Flow
RCAT
RCAT
WVE
WVE
Q3 25
$-24.5M
Q2 25
$-46.3M
Q1 25
$-16.2M
$-63.2M
Q4 24
$-10.2M
Q2 24
$-27.5M
Q1 24
$-4.2M
$-33.8M
Q4 23
$-33.6M
Q3 23
$-34.7M
FCF Margin
RCAT
RCAT
WVE
WVE
Q3 25
-254.2%
Q2 25
-532.5%
Q1 25
-992.9%
-688.9%
Q4 24
Q2 24
-139.8%
Q1 24
-71.1%
-270.0%
Q4 23
-115.6%
Q3 23
-70.4%
Capex Intensity
RCAT
RCAT
WVE
WVE
Q3 25
6.9%
Q2 25
3.5%
Q1 25
16.8%
1.8%
Q4 24
Q2 24
0.3%
Q1 24
0.8%
3.3%
Q4 23
1.2%
Q3 23
0.4%
Cash Conversion
RCAT
RCAT
WVE
WVE
Q3 25
Q2 25
Q1 25
Q4 24
Q2 24
Q1 24
Q4 23
Q3 23
-4.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RCAT
RCAT

Products$8.5M88%
Services$1.2M12%

WVE
WVE

Segment breakdown not available.

Related Comparisons